These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10597280)

  • 1. The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RAR beta signaling pathways in breast cancer cells.
    Shang Y; Baumrucker CR; Green MH
    Oncogene; 1999 Nov; 18(48):6725-32. PubMed ID: 10597280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells.
    Grunt TW; Tomek K; Wagner R; Puckmair K; Zielinski CC
    Differentiation; 2007 Nov; 75(9):883-90. PubMed ID: 17608728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
    Zhu WY; Jones CS; Amin S; Matsukuma K; Haque M; Vuligonda V; Chandraratna RA; De Luca LM
    Cancer Res; 1999 Jan; 59(1):85-90. PubMed ID: 9892191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.
    Dietze EC; Caldwell LE; Marcom K; Collins SJ; Yee L; Swisshelm K; Hobbs KB; Bean GR; Seewaldt VL
    Microsc Res Tech; 2002 Oct; 59(1):23-40. PubMed ID: 12242694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.
    Johnson MR; Valentine C; Basilico C; Mansukhani A
    Oncogene; 1998 May; 16(20):2647-56. PubMed ID: 9632141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
    Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
    Widschwendter M; Daxenbichler G; Dapunt O; Marth C
    Cancer Res; 1995 May; 55(10):2135-9. PubMed ID: 7743514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL; Herrera RE; Yee D
    Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
    Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
    Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
    Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
    Fanjul AN; Bouterfa H; Dawson M; Pfahl M
    Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
    Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
    Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth.
    Li XS; Shao ZM; Sheikh MS; Eiseman JL; Sentz D; Jetten AM; Chen JC; Dawson MI; Aisner S; Rishi AK
    J Cell Physiol; 1995 Dec; 165(3):449-58. PubMed ID: 7593223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells.
    Arany I; Ember IA; Tyring SK
    Anticancer Res; 2003; 23(1A):471-3. PubMed ID: 12680251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
    Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.